2,5-Dichloro-N-[2-[[(1R)-1-[(3aS,4S,6S,7aR)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]amino]-2-oxoethyl]-benzamide is an intermediate used in the synthesis of Ixazomib (I942000), which is a proteasome inhibitor that acts by preventing cell growth in solid tumours. It is an anticancer agent that is used to treat patients with multiple myeloma and is potentially neurotoxic.
SKU | RCLST042044 |
---|---|
CAS number | 1201903-02-7 |
Molecular Formula | C24H33BCl2N2O4 |
Catalog Number | RCLST042044 |
Chemical Name | 2,5-Dichloro-N-[2-[[(1R)-1-[(3aS,4S,6S,7aR)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]amino]-2-oxoethyl]-benzamide |
Molecular Weight | 495.25 |
Solubility | Dichloromethane; Chloroform; Methanol; Ethyl Acetate; DMSO; |
Stability | No Data Available |
Appearance | White Solid |
Storage Condition | -20°C Freezer |